PCIORGA Stock Latest News
Private CompaniesiOrganBio Highlights Single-Cell Sequencing for Adaptive Cell Manufacturing13h agoIORGA
Private CompaniesiOrganBio Marks First Year with Team Growth and Platform Efficiency Gains1d agoIORGA
Private CompaniesiOrganBio Links Digitized Cell States to Chemical Discovery1w agoIORGA
Private CompaniesiOrganBio and Mitsui Chemicals Target Scalable Cell and Organoid Manufacturing1w agoIORGA
Private CompaniesiOrganBio to Present Stem-Cell Manufacturing and Discovery Platforms2w agoIORGA
Private CompaniesTranscriptomics-Based Potency Assessment Emerges as Focus in Cell Therapy Quality3w agoIORGA
Private CompaniesAI-Driven Cell Manufacturing Strategy Positions iOrganBio in Regenerative Medicine1M agoIORGA
Private CompaniesiOrganBio Highlights Strategic Focus on Scalable Stem Cell Therapy Manufacturing1M agoIORGA
Private CompaniesiOrganBio Joins ARMI to Advance Automated Cell Manufacturing1M agoIORGA
Private CompaniesiOrganBio Highlights Leadership Presence at Biotech Week Boston2M agoIORGAPrivate CompaniesiOrganBio Highlights Role in NAMs and iPSC Technologies at PluriCon 20262M agoIORGA
Private CompaniesAdaptive Cell Manufacturing Platform Highlights Focus on Scalable GMP-Grade Production2M agoIORGA
Private CompaniesTumor Organoid Advances Underscore Emerging Opportunities in Precision Oncology2M agoIORGA
Private CompaniesImplications of Emerging Organoid Complexity Trends for iOrganBio2M agoIORGA
Private CompaniesNIH Funding Push for Human-Based Research Highlights Potential Tailwind for iOrganBio3M agoIORGA
Private CompaniesCustomized Organoid Models Underscore iOrganBio’s Preclinical Strategy3M agoIORGAPrivate CompaniesOrganoid-Based Ebola Research Underscores Potential of Human-Relevant Disease Models3M agoIORGA
Private CompaniesAI-Driven Preclinical Models Spotlight iOrganBio’s Drug Discovery Ambitions3M agoIORGA


